Ebola GP1 Surface Protein Humanized Antibody (Ansuvimab)

Ebola GP1 Surface Protein Humanized Antibody (Ansuvimab)is available at Gentaur for Next week Delivery.

Description: This research-grade biosimilar is a humanized antibody that targets the envelope glycoprotein of Ebola virus. Infection with pathogenic filoviruses such as Ebola can cause severe hemorrhagic fever in humans, with fatality rates as high as 90%. The envelope glycoprotein complex is responsible for the viral entry into host cells via binding to host surface receptors. The most successful methods for treatment of Ebola involve the targeting of its surface glycoproteins. The original humanized monoclonal antibody was shown to successfully treat Ebola patients, with improved patient survival and more efficient viral clearance.

Immunogen Sequence:FAUX

Target Alternative Name:GP; GP1; GP2; Shed GP; Second secreted glycoprotein; small secreted glycoprotein; spike glycoprotein

Species Reactivities:Ebola Virus

Tag Line:A humanized monoclonal antibody that targets the Ebola virus envelope glycoprotein

Formulation:In PBS, pH 7.5

Purification: FAUX

Application:FAUX

Positive Control:/

Application And Usages:/

Handling:The antibody solution should be gently mixed before use.